Table 2.
Characteristics of women who were born very or moderately preterm, late preterm, and full term (controls). Data are presented as mean ± s.d. or as n (%).
VMPT, n = 74 | LPT, n = 127 | Controls, n = 184 | |||
---|---|---|---|---|---|
Values | P-valuea | Values | P-valuea | ||
Age mean, years | 23.0 ± 1.3 | <0.001 | 23.1 ± 1.2 | <0.001 | 23.5 ± 1.1 |
Height, cm | 163.3 ± 5.1 | 0.547 | 164.6 ± 5.7 | 0.761 | 163.9 ± 5.9 |
Weight, kg | 62.4 ± 0.26 | 0.999 | 62.2 ± 0.19 | 0.200 | 60.7 ± 0.20 |
BMI, kg/m2 | 22.8 ± 0.24 | 0.725 | 22.4 ± 0.18 | 0.227 | 22.0 ± 0.19 |
WC, cm | 77.3 ± 0.17 | 0.065 | 75.8 ± 0.12 | 0.014 | 73.6 ± 0.13 |
Body fat percentage | 28.7 ± 0.30 | 0.313 | 27.1 ± 0.27 | 0.101 | 25.9 ± 0.31 |
Fasting insulin, µU/mL | 7.66 ± 0.65 | 0.295 | 7.37 ± 0.60 | 0.025 | 6.74 ± 1.52 |
120 min insulin µU/mL | 30.90 ± 0.85 | 0.071 | 30.84 ± 0.85 | 0.040 | 28.46 ± 1.88 |
HOMA-IR | 0.99 ± 0.63 | 0.507 | 0.96 ± 0.60 | 0.037 | 0.88 ± 1.50 |
TS, nmol/L | 1.44 ± 1.48 | 0.857 | 1.35 ± 1.44 | 0.864 | 1.00 ± 1.00 |
Elevated TS levelsb | 6 (8.8%) | 0.128 | 3 (2.5%) | 0.495 | 7 (4.0%) |
SHBG, nmol/L | 112.89 ± (2.32) | 0.044 | 142.40 ± (2.38) | 0.107 | 149.05 ± 2.39 |
Free androgen index | 1.32 ± 2.57 | 0.313 | 1.15 ± 2.54 | 0.414 | 0.87 ± 2.74 |
Physical activity, METh/wk* | 23.5 ± 12.7 | 0.145 | 24.9 ± 14.5 | 0.676 | 24.3 ± 11.9 |
Daily smoking | 23 (31.1%) | 0.046 | 26 (20.5%) | 0.844 | 36 (19.6%) |
Hormonal contraception | 24 (32.4%) | 0.244 | 45 (35.4%) | 0.394 | 74 (40.2%) |
Hirsutism | 11 (15.7%) | 0.386 | 20 (16.7%) | 0.190 | 20 (11.4%) |
Irregular menstrual cycle | 34 (49.3%) | 0.383 | 50 (42.7%) | 0.587 | 68 (39.5%) |
Menstrual cycle >35 days | 11 (16.2%) | 0.407 | 13 (11.2%) | 0.351 | 17 (10.1%) |
PCOSc | 4 (5.4%) | 0.530 | 16 (12.6%) | 0.143 | 14 (7.6%) |
aPearson’s chi-square test for categorical variables and Dunnett’s t-test in many-to-one comparisons for continuous variables, VMPT or LPT vs controls; bTestosterone > 2.4 nmol/L; cPCOS according to biochemical and clinical signs; *Self reported leisure time physical activity.
HOMA-IR, homeostatic model assessment of insulin resistance; LPT, late preterm; METh, metabolic equivalent task hours; PCOS polycystic ovary syndrome; SHBG, sex hormone binding globulin; VMPT very or moderately preterm; WC, waist circumference; TS, testosterone.